Simran Farms Limited (BOM:519566)

Theseus Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	20.41	121.83	60.65	159.38	191.15
Cash & Short-Term Investments	20.41	121.83	60.65	159.38	191.15
Cash Growth	-83.25%	100.87%	-61.94%	-16.62%	65.52%
Accounts Receivable	168.52	133.36	97.8	82.29	77.39
Receivables	173.76	137.35	99.94	85.31	96.35
Inventory	1,396	834.79	712.53	500.08	383.03
Prepaid Expenses	-	2.18	2.27	1.38	1.21
Other Current Assets	35.75	24.76	10.64	27.27	26.93
Total Current Assets	1,626	1,121	886.03	773.4	698.68
Property, Plant & Equipment	236.14	230.33	234.69	214.83	204.06
Long-Term Investments	1.19	1.19	1.19	1.19	1.19
Long-Term Deferred Tax Assets	28.43	36.25	40.61	28.85	13.05
Other Long-Term Assets	-	3	2.91	2.81	2.38
Total Assets	1,895	1,392	1,165	1,021	919.36
Accounts Payable	975.23	662.4	490.6	407.9	384.38
Accrued Expenses	4.6	31.99	25.95	23.32	18.96
Short-Term Debt	-	344.63	288.24	273.93	273.27
Current Portion of Long-Term Debt	412.96	5.07	5.08	2.89	2.97
Current Income Taxes Payable	-	1.57	10.03	12.52	34.45
Other Current Liabilities	72.91	17.97	17.58	17.19	24.85
Total Current Liabilities	1,466	1,064	837.47	737.74	738.86
Long-Term Debt	1.53	3.29	8.4	2.05	1.99
Other Long-Term Liabilities	15.63	1.6	1.6	1.76	1.76
Total Liabilities	1,483	1,076	852.89	743.68	744.66
Common Stock	37.92	37.92	37.92	37.92	37.92
Additional Paid-In Capital	-	16.96	16.96	16.96	16.96
Retained Earnings	-	256.22	253.7	218.82	115.92
Comprehensive Income & Other	369.52	0.05	0.05	-0.04	0.05
Total Common Equity	407.44	311.15	308.63	273.66	170.85
Minority Interest	4.24	4.07	3.92	3.73	3.85
Shareholders' Equity	411.68	315.22	312.54	277.39	174.7
Total Liabilities & Equity	1,895	1,392	1,165	1,021	919.36
Total Debt	414.49	352.99	301.71	278.87	278.22
Net Cash (Debt)	-394.08	-231.16	-241.06	-119.49	-87.07
Net Cash Per Share	-96.58	-60.96	-63.58	-31.51	-22.96
Filing Date Shares Outstanding	3.79	3.79	3.79	3.79	3.79
Total Common Shares Outstanding	3.79	3.79	3.79	3.79	3.79
Working Capital	160.14	57.28	48.56	35.66	-40.19
Book Value Per Share	107.41	82.06	81.40	72.17	45.06
Tangible Book Value	407.44	311.15	308.63	273.66	170.85
Tangible Book Value Per Share	107.41	82.06	81.40	72.17	45.06
Land	-	71.41	71.41	52.61	52.72
Buildings	-	126.69	125.42	124.63	106.45
Machinery	-	312.5	300.2	281.17	260.89
Construction In Progress	-	-	-	-	6.88

Source: S&P Global Market Intelligence. Standard template. Financial Sources.